ArticleBiomedicines2025

Alpha-Lipoic Acid Treatment Reduces the Levels of Advanced End Glycation Products in Type 2 Diabetes Patients with Neuropathy.

Sára Csiha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.